| Trial Identifier: | D9440C00001 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Parexel
|
| NCTID:: | NCT06122714 |
| Start Date: | November 2023 |
| Primary Completion Date: | October 2024 |
| Study Completion Date: | October 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, CA | Glendale, CA, US, 91206 |
| US, MD | Brooklyn, MD, US, 21225 |